WebbK36 THERAPEUTICS, INC. is a Massachusetts Foreign Profit Corporation filed on February 17, 2024. The company's File Number is listed as 001488553. The Registered … WebbLegal Name Kinaset Therapeutics, Inc. Company Type For Profit Phone Number (508) 858-5810 Kinaset Therapeutics is a therapeutics company that focuses on the advancement of novel drugs in areas of unmet medical needs. The company was founded in 2024 and is headquartered in Medfield, Massachusetts. Lists Featuring This Company

K36 Therapeutics announces dosing of first patient in KTX-1001 …

Webb23 aug. 2024 · K36 Therapeutics, Inc. Aug 23, 2024, 07:00 ET KTX-1001 is a first-in-class, potent, and selective inhibitor of multiple myeloma SET domain (MMSET) for the treatment of patients with relapsed... Webb11 apr. 2024 · CAMBRIDGE, Mass., April 11, 2024 /PRNewswire/ -- K36 Therapeutics ("K36"), a privately held biotechnology company developing KTX-1001, an investigational small molecule methyltransferase inhibitor ... toyslyus

K36 Therapeutics - Atlas Venture

Webb9 dec. 2024 · K36 Therapeutics has come out of the gates with $30 million in venture funding to back a small-molecule oral treatment from Novartis. WebbK36 Therapeutics - Atlas Venture K36 Therapeutics Translating epigenetic modulation of oncogenic pathways into first-in-class small molecule therapeutics Effective treatment options for t (4;14)-positive multiple myeloma patients … Webb9 dec. 2024 · Atlas, F-Prime launch K36 Therapeutics to advance oncology molecule for elusive epigenetic target – Endpoints News. Terry Connolly, K36 Therapeutics CEO. … toysly off-road pickup j40 land cruiser